Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robotic exoskeleton takes on conventional therapy in spinal cord injury recovery trial

NCT ID NCT06775925

Disease control Sponsor: Swiss Paraplegic Research, Nottwil Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests whether robot-assisted therapy using the ArmeoSpring exoskeleton improves arm and hand function more than conventional occupational therapy in people with cervical spinal cord injury. Each participant receives both therapies in random order, allowing direct comparison. The study focuses on grasp performance and daily independence during early rehabilitation.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
ArmeoSpring exoskeleton (robot-assisted therapy)
What this could lead to
If robot-assisted therapy proves more effective, it could offer a new, standardized option to improve arm and hand function after cervical spinal cord injury.
What could go wrong
This is a small, early-stage crossover trial with only 40 participants. The ArmeoSpring provides weight support but no active movement, so gains may be modest and may not apply to all injury levels.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 40 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2025

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Informed Consent signed by the subject * Intermediate (\>16 days and ≤81 days post-injury) traumatic or non-traumatic cSCI during primary rehabilitation at the Swiss Paraplegic Centre (SPC) * Neurological level of injury: C1-T1 * American Spinal Injury Association Impairment Scale (AIS): A-D * Impairment of upper limb function (GRASSP-QtG score unilateral \< 25 at baseline t0) * Ability to sit for 60 minutes and perform training with ArmeoSpring * Stratification parameters available Exclusion Criteria: * Inability to follow the procedures of the investigation * Severe concomitant neurological disease * Concomitant neurodegenerative or progressive diseases * Impairment of upper limb function due to peripheral nerve lesions * Severe concurrent medical disease or any other issue that in the opinion of the investigator would confound the results * Orthopedic limitations of the upper limb * Device specific contraindications * Participation in other interventional trials

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cervical spinal cord injury are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

spinal cord injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cervical spinal cord injury

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Swiss Paraplegic Centre

    RECRUITING

    Nottwil, Canton of Lucerne, 6207, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.